TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group

by Cremolini, Chiara, Marmorino, Federica, Loupakis, Fotios, Masi, Gianluca, Antoniotti, Carlotta, Salvatore, Lisa, Schirripa, Marta, Boni, Luca, Zagonel, Vittorina, Lonardi, Sara, Aprile, Giuseppe, Tamburini, Emiliano, Ricci, Vincenzo, Ronzoni, Monica, Pietrantonio, Filippo, Valsuani, Chiara, Tomasello, Gianluca, Passardi, Alessandro, Allegrini, Giacomo, Di Donato, Samantha, Santini, Daniele, Falcone, Alfredo
Published in BMC Cancer (2017)

Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Tri...

by Cremolini, Chiara, Rossini, Daniele, Dell’Aquila, Emanuela, Lonardi, Sara, Conca, Elena, Del Re, Marzia, Busico, Adele, Pietrantonio, Filippo, Danesi, Romano, Aprile, Giuseppe, Tamburini, Emiliano, Barone, Carlo, Masi, Gianluca, Pantano, Francesco, Pucci, Francesca, Corsi, Domenico C., Pella, Nicoletta, Bergamo, Francesca, Rofi, Eleonora, Barbara, Cecilia, Falcone, Alfredo, Santini, Daniele
Published in JAMA Oncol (2018)

Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized...

by Cremolini, Chiara, Antoniotti, Carlotta, Lonardi, Sara, Aprile, Giuseppe, Bergamo, Francesca, Masi, Gianluca, Grande, Roberta, Tonini, Giuseppe, Mescoli, Claudia, Cardellino, Giovanni Gerardo, Coltelli, Luigi, Salvatore, Lisa, Corsi, Domenico Cristiano, Lupi, Cristiana, Gemma, Donatello, Ronzoni, Monica, Dell’Aquila, Emanuela, Marmorino, Federica, Di Fabio, Francesca, Mancini, Maria Laura, Marcucci, Lorenzo, Fontanini, Gabriella, Zagonel, Vittorina, Boni, Luca, Falcone, Alfredo
Published in JAMA Oncol (2018)